Compare OBK & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBK | CDNA |
|---|---|---|
| Founded | 1912 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.1B |
| IPO Year | 2018 | 2007 |
| Metric | OBK | CDNA |
|---|---|---|
| Price | $50.14 | $22.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | ★ $46.67 | $28.00 |
| AVG Volume (30 Days) | 101.5K | ★ 674.8K |
| Earning Date | 04-22-2026 | 04-28-2026 |
| Dividend Yield | ★ 2.13% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.89 | 0.05 |
| Revenue | N/A | ★ $48,324,000.00 |
| Revenue This Year | $26.43 | $16.01 |
| Revenue Next Year | $5.79 | $11.31 |
| P/E Ratio | ★ $55.69 | $473.20 |
| Revenue Growth | N/A | ★ 18.93 |
| 52 Week Low | $32.13 | $10.96 |
| 52 Week High | $49.72 | $24.13 |
| Indicator | OBK | CDNA |
|---|---|---|
| Relative Strength Index (RSI) | 68.02 | 56.97 |
| Support Level | $46.28 | $16.41 |
| Resistance Level | N/A | $22.89 |
| Average True Range (ATR) | 0.97 | 1.04 |
| MACD | 0.21 | 0.03 |
| Stochastic Oscillator | 99.88 | 54.29 |
Origin Bancorp Inc is a financial holding company that provides personalized, relationship banking to businesses, municipalities, and personal clients in the communities it serves. The company offers a broad range of financial services and operates more than 56 locations in Dallas/Fort Worth, East Texas, Houston, North Louisiana, Mississippi, South Alabama, and the Florida Panhandle. It also provides insurance agency products and services through its wholly owned insurance agency subsidiary. The company operates in one business segment, community banking, and is mainly engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.